Celsion Corporation CLSN announced results from phase Ib study — OVATION ... Investors cheered the news as the stock skyrocketed over 300% on Tuesday. In fact, shares of the company have surged 42.4% so far this year, …
The stock lost 24.8% in the last one year ... Story Continues Based in Lawrenceville, NJ, Celsion Corporation CLSN is an oncology company committed to developing a portfolio of innovative cancer treatments, including directed …
Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO …
Investors in Endocyte (ECYT) need to pay close attention to the stock based on moves in the options market lately. WEST LAFAYETTE, Ind., Dec. 15, 2017-- Endocyte, Inc., a biopharmaceutical company developing targeted therapeutics for …
Investors in Endocyte (ECYT) need to pay close attention to the stock based on moves in the options market lately. WEST LAFAYETTE, Ind., Dec. 15, 2017-- Endocyte, Inc., a biopharmaceutical company developing targeted therapeutics for …